Targeting Therapeutics Across the Blood Brain Barrier (BBB), Prerequisite Towards Thrombolytic Therapy for Cerebrovascular Disorders—an Overview and Advancements
Crossref DOI link: https://doi.org/10.1208/s12249-015-0287-z
Published Online: 2015-01-23
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pulicherla, K. K.
Verma, Mahendra Kumar
Text and Data Mining valid from 2015-01-23